Probiotics, like lactic acid bacteria, are non-pathogenic microbes that exert health benefits to
the host when administered in adequate quantity. Currently, research is being conducted on …

The occurrence and development of cardiovascular-related diseases are associated with
structural and functional changes in gut microbiota (GM). The accumulation of beneficial gut …

The present research explored the effects of Bacillus subtilis on water quality, growth,
immune responses, endotoxemia and protection against lipopolysaccharide (LPS) damages …

Lactobacillus plantarum ZS62 is a newly isolated strain from naturally fermented yogurt that
might offer some beneficial effects in the setting of alcohol‐induced subacute liver injury …

Hypercholesterolemia is the main cause of cardiovascular disease worldwide, and the
regulation of cholesterol homeostasis is essential for human health. Lactobacillus is present …

Atherosclerosis is a chronic, progressive, inflammatory disease in the vasculature and is
common in both coronary and peripheral arteries. Human beings harbor a complex and …

Globally, foodborne diseases (FBDs) result in millions of sicknesses and deaths annually.
Cumulative evidence suggests that the use of probiotic lactic acid bacteria (LAB) strains …

Hypercholesterolemia is a risk factor for cardiovascular diseases, and hence, reducing
serum cholesterol levels could reduce the incidence. In this study, we ascertained the …

Atherosclerosis is the leading cause of cardiovascular diseases worldwide. Trimethylamine
N-oxide (TMAO), a metabolite of intestinal flora from dietary quaternary amines, has been …

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent metabolic
disease that has no effective treatment. Our proprietary probiotic mixture, Prohep, has been …